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http://www.biomedcentral.com/1471-2474/14/182RESEARCH ARTICLE Open AccessStability of conditioned pain modulation in two
musculoskeletal pain models: investigating the
influence of shoulder pain intensity and gender
Carolina Valencia1, Lindsay L Kindler2, Roger B Fillingim3 and Steven Z George4,5*Abstract
Background: Several chronic pain populations have demonstrated decreased conditioned pain modulation (CPM).
However there is still a need to investigate the stability of CPM paradigms before the measure can be
recommended for implementation. The purpose of the present study was to assess whether shoulder pain intensity
and gender influence CPM stability within and between sessions.
Methods: This study examined two different musculoskeletal pain models, clinical shoulder pain and an
experimental model of shoulder pain induced with eccentric exercise in healthy participants. Patients in the clinical
cohort (N = 134) were tested before surgery and reassessed 3 months post-surgery. The healthy cohort (N = 190)
was examined before inducing pain at the shoulder, and 48 and 96 hours later.
Results: Our results provide evidence that 1) stability of inhibition is not related to changes in pain intensity, and 2)
there are sex differences for CPM stability within and between days.
Conclusions: Fluctuation of pain intensity did not significantly influence CPM stability. Overall, the more stable
situations for CPM were females from the clinical cohort and males from the healthy cohort.
Keywords: Conditioned pain modulation, Stability, Shoulder painBackground
Various quantitative sensory testing (QST) modalities
have been used to assess particular mechanisms of pain
perception in healthy individuals and those with chronic
pain. Conditioned pain modulation (CPM) is one QST
methodology with purported clinical relevance [1,2] and
potential to predict the development of chronic pain [3].
This test paradigm has been previously described as dif-
fuse noxious inhibitory controls but a recent consensus
[4] concluded that the term CPM more accurately
describes the testing phenomenon being observed. In
short, CPM uses a “pain inhibits pain” test paradigm to
activate the descending endogenous analgesia system [5].
It is believed that one noxious conditioning stimulus
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reproduction in any medium, provided the oractivating a spinal-supraspinal-spinal loop, resulting in
functional inhibitory pain modulation [1]. The inability
of the noxious conditioning stimulus to decrease the
pain intensity of the noxious testing stimulus indicates a
potential deficiency in the body’s endogenous pain mod-
ulatory ability. Several chronic pain populations, includ-
ing fibromyalgia [6], tempromandibular joint disorder
[7], and irritable bowel syndrome [8], have demonstrated
decreased CPM efficiency. These results, along with
others showing the association of CPM with the devel-
opment of chronic pain [3], resolution of pain following
treatment [9], and ability to predict clinical pain [1], has
led researchers to advocate for CPM as a clinically rele-
vant QST modality [10].
Recently, efforts have gone into standardizing proce-
dures used to assess CPM [4,5,11]; however there is still
a need to investigate factors that influence CPM stability.
One investigation that examined the test retest reliability
of CPM in a small sample of healthy subjects found high
reliability among repeated testing within a single sessionl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Valencia et al. BMC Musculoskeletal Disorders 2013, 14:182 Page 2 of 10
http://www.biomedcentral.com/1471-2474/14/182[11], however the exploration of CPM reliability in dif-
ferent musculoskeletal pain models has not yet been
described. This is an important issue which would have
implications for use of this measure in clinical popula-
tions. Since the evidence shows a dysfunction of en-
dogenous analgesia system among chronic pain groups
[12], it is reasonable to think that CPM reliability could
be affected by having the system already engaged with the
presence of shoulder pain. Furthermore, since sex differ-
ences in pain related responses to experimental pain mea-
sures have also been reported [13,14], the effect of sex on
reliability of CPM also has clinical implications.
Therefore, the present study used two different mus-
culoskeletal pain models to assess whether presence of
shoulder pain and gender influence CPM stability within
and between sessions. To serve this purpose, this study
examined patients with acute and sub-acute shoulder
pain preparing to undergo shoulder surgery, and healthy
subjects with exercise induced muscle pain (EIMP) at
the shoulder [15,16]. Understanding how shoulder pain
and gender affect pain inhibitory responses, and esti-
mating the error associated with this commonly used
measure, will add to our understanding of CPM provid-
ing clinical relevance for this particular experimental
pain measure.Methods
Subjects
The University of Florida’s institutional review board for
human participants approved this study. This prospect-
ive design was part of a larger study and includes two
groups of participants, a clinical cohort of patients hav-
ing shoulder surgery, and a healthy cohort. All partici-
pants provided informed consent before participating in
this study.Clinical cohort (clinical pain model)
This study includes data from consecutive patients seek-
ing treatment of shoulder disorder, which were recruited
from University of Florida’s Orthopedics Sports Medi-
cine Institute (OSMI). The inclusion criteria for being a
participant in the clinical cohort were: patient between
18 and 85 years of age, complaints of pain limited to
anterior, lateral, or posterior shoulder, rotator cuff ten-
dinopathy, adhesive capsulitis, SLAP (Superior Labrum
from Anterior to Posterior) lesion, and scheduled for
arthroscopic surgery. Exclusion criteria for the prospective
clinical cohort were: current complaints of pain greater
than the past 3 months involving neck, elbow, hand, low
back, hip, knee, or ankle, massive or complete rotator cuff
tear, shoulder OA or RA, prior shoulder surgery within
the past year, current shoulder fracture, tumor, or infec-
tion, previously diagnosed chronic pain disorder, currentpsychiatric management, and gastrointestinal or renal
illness [17].Healthy cohort (acute pain model)
Healthy volunteers were recruited via advertisements
from the University and local community. The inclusion
criteria for the healthy cohort were: healthy subjects (with-
out any pain or psychological condition) between 18 and
85 years of age, and English speaking. The exclusion cri-
teria were: history of neck or shoulder injury, sensory or
motor impairment of the shoulder, regular or recent par-
ticipation in high or low intensity upper-extremity weight
training, or currently taking pain medication. These eligi-
bility criteria have been used in our previous studies of
exercise-induced shoulder pain [15,16].Measures and procedure
Demographic information
Study participants completed a standard intake informa-
tion form. Demographic data collected at initial evalu-
ation included gender, age, race, ethnicity, employment
status, marital status, and educational level.Conditioned pain modulation (CPM)
Test stimulus Suprathreshold heat pain response
(SHPR) was used as the test stimulus. Pathway Pain &
Sensory Evaluation System (Medoc, Ramat Yishai, Israel),
with a thermode of 2.5 cm2 surface area was used. Se-
quences of 5 consecutive heat pulses of < 1-second dur-
ation at interpulse intervals of 0.33 Hz were delivered to
the thenar eminence of the non-surgical side for the clin-
ical cohort, and non-dominant side for the healthy cohort,
as previously described [18-20]. The temperature used for
the test stimulus was determined from a previous SHPR
assessment (five minutes before CPM assessment). One
series of five stimuli was applied at each of three different
target temperatures (46°C, 48°C and 50°C), and the
temperature that produced an average pain intensity score
closest to 50 on a 0-100 visual analogue scale (VAS) was
used for the test stimulus in the CPM protocol completed
on that day. This process was repeated each day that CPM
was assessed to determine the temperature necessary to
evoke moderate pain during the test stimuli. Subjects
verbally rated the intensity of each thermal pulse on a nu-
merical rating scale from 0 = “no pain” to 100 = “the worst
pain imaginable” [19]. We selected SHPR as the test
stimulus because evidence suggests that CPM effects are
largest for C-fiber mediated pain [21,22]. For analyses pur-
poses, this study used the “5th pain rating” which was the
fifth pain rating from the fifth pulse of each trial [23-26],
which is considered to represent a simple measure of
SHPR assessment [27].
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were instructed to immerse their surgical side hand (for
the clinical cohort), and dominant hand (in healthy co-
hort) up to the wrist into a cold water bath for up to
one minute. The water was maintained at a constant
temperature of 8°C by a refrigerated water circulator,
and was constantly circulated to prevent warming
around the hand.
CPM procedure Participants from both cohorts under-
went the CPM assessment with the application of the
test stimulus (described above) on the non-surgical side
for the clinical cohort, and non-dominant side for the
healthy cohort. After 30 s from the last heat stimulus,
subjects were instructed to immerse their contralateral
hand up to the wrist into the cold water bath (condition-
ing stimulus). Thirty seconds after hand immersion, sub-
jects were asked to rate the pain intensity (0-100) from
the immersed hand, and were instructed to maintain
their hand in the water bath for as long as they could
tolerate for a maximum of one minute. One minute after
the immersion of the hand, a new test stimulus was
delivered on the non-surgical side for the clinical cohort,
and non-dominant side for the healthy cohort. The proto-
col was created with consecutive stimuli (test stimulus,
then conditioning stimulus, hand removed from water,
and then test stimulus). This sequence of delivering the
test stimuli, followed by the conditioning stimulus, and
ending with re-delivering the test stimuli constituted the
first CPM trial (CPM1). After a two-minute rest period,
the CPM protocol was repeated in exactly the same man-
ner for a second trial (CPM2).
Exercise induced muscle pain (EIMP)
Pain was induced in subjects from the healthy cohort
with a shoulder fatigue procedure using a Kin-Com
(Chattanooga, TN) isokinetic dynamometer. Upper ex-
tremity EIMP is considered a clinically relevant pain
model since participants experience increased pain in-
tensity, decreased range of motion, an inflammatory re-
sponse, altered proprioception, and the use of self-care
behaviors [28-32]. Muscle soreness occurs within 24 hours
following the shoulder fatigue procedure with maximal
soreness typically lasting 48 hours from the time of the
procedure [28]. Subjects typically experience decreasing
levels of muscle soreness three to five days post-shoulder
fatigue protocol.
Maximum voluntary isometric contraction (MVIC)
was determined by having the participants perform ex-
ternal rotation contractions with maximal effort while
receiving verbal encouragement during the contractions.
The MVIC was calculated by averaging the peak force
from the middle 3 repetitions, a method with docu-
mented reliability from previous studies [33,34]. AfterMVIC was calculated, participants completed eccentric/
concentric external rotation repetitions to induce muscle
fatigue. Previously established procedures were utilized
to induce pain in this cohort, which is described in more
detail in our previous studies [15,16].
Pain intensity
These data were included to describe the effects of
clinical pain (surgical cohort) and exercise-induced
shoulder pain (healthy cohort) on CPM stability. Pain
intensity in both cohorts was assessed with the Brief
Pain Inventory (BPI) questionnaire [35], which includes
a numerical rating scale (NRS) for pain intensity. Sub-
jects from the clinical cohort (before and 3 months
after surgery) and from the healthy cohort (after EIMP
protocol) rated their pain intensity over three condi-
tions, the present pain intensity, the worst pain inten-
sity over the past 24 h, and the best pain intensity over
the past 24 h. These 3 ratings were averaged for use in
data analyses [36,37].
Testing sequence
Patients from the clinical cohort had a baseline examin-
ation (baseline) to collect demographic data, shoulder
pain intensity, and quantitative sensory testing 72 to
24 hours before the surgery. They were reassessed
3 months after the surgery (3 months). Subjects from
the healthy cohort were scheduled to come to the testing
facility on day 1, day 3, and day 5. On Day 1, subjects
had a baseline examination to collect demographic data,
shoulder pain intensity, and quantitative sensory testing
(CPM and pain threshold) in a pain free state. Subjects
completed strength testing, followed by eccentric/con-
centric external rotation repetitions to induce muscle
fatigue. Collection of quantitative sensory testing and
shoulder pain intensity was repeated on days 3 and 5 fol-
lowing EIMP induction.
Data analysis
Data analysis was performed in SPSS, Version 19.0 at
alpha level of 0.05. Descriptive statistics (mean, stand-
ard deviation) were calculated for all variables. The
distributions of variables were tested by visual examin-
ation and with Kolmogorov-Smirnov test before use in
analysis.
Calculations for CPM
For analysis purposes on CPM, we followed recent rec-
ommendations [4] on presenting results and calculation
of CPM using the absolute difference for CPM and the
percent change. The “absolute difference” for CPM, was
calculated by the difference between test stimulus before
the application of conditioning stimulus (pre CPM), minus
the test stimulus after the application of conditioning
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calculated as follows:
post CPM pre CPMð Þ=pre CPM½ 100
For each session there were two absolute difference
and two percent change scores for CPM variables; one
from the first CPM trial (CPM trial 1) and one from the
second CPM trial (CPM trial 2). CPM trials were re-
peated before and 3 month after the surgery for the clin-
ical cohort, and on three different days (Days 1, 3, and
5) for the healthy cohort.
Clinical cohort
Stability analyses for CPM measures included intraclass
correlations (ICC’s) for the absolute difference of CPM
and the percent change of CPM only within session (trial
1 and trial 2). These results were reported with the ap-
propriate coefficient and 95% confidence interval (CI).
From these data the standard error of measurement
(SEM) was calculated for each measure using a previ-
ously described method [standard deviation*√(1 – test
rest reliability coefficient)] [38-40]. The minimal detect-
able change (MDC95) was calculated using a previously
described method (1.96*SEM*√2) [41]. The stability esti-
mates (SEM and MDC95) provide an idea of how much
individual change is necessary before measurement error
is likely to have been exceeded. To determine whether
sex influences CPM stability, ICC’s stratified by sex were
also reported.
Repeated measures ANOVAs were used to assess the
effect of trial (trial 1 and trial 2) on within session for
the absolute difference of CPM. Next, shoulder pain in-
tensity was included as a covariate to investigate the
impact that pain intensity had on CPM stability. The
analysis was performed separately for each session of the
clinical cohort (session 1 and 3 months).
Healthy cohort
Stability analyses for CPM measures included intraclass
correlations (ICC’s) for the absolute difference of CPM
and the percent change of CPM within session (trial 1
and trial 2) and between sessions (day 1, day 3, and day
5). As in the clinical cohort, these results were reported
with the appropriate 95% CI, SEM, and the MDC95.
ICC’s stratified by sex were also reported.
Repeated measures ANOVAs were used to assess the
effect of trial (trial 1 and trial 2) on within session for
the absolute difference of CPM. The analysis was per-
formed separately for each session of the healthy cohort
(day 1, day 3, and day 5). In addition, repeated measures
ANOVA were used to assess the effect of time (day 1,
day 3, and day 5) on the absolute difference of CPM
with and without the inclusion of shoulder pain intensityas a covariate to investigate the impact that pain inten-
sity had on CPM stability on between sessions.
Results
Subjects
A total of 134 subjects from the clinical cohort, and 190
subjects from the healthy cohort recruited from March
2009 to May 2012 were included in this analysis. De-
scriptive statistics for the measures are summarized in
Table 1 for the clinical and healthy cohorts. Absolute
change and percent change of CPM stratified by sex are
summarized in Table 2 for both cohorts. All variables
were found to approximate a normal distribution by
visual examination and Kolmogorov-Smirnov test (p >
0.05), and were therefore deemed appropriate for our
planned parametric analyses.
Clinical cohort
Table 3 shows stability results from the clinical cohort
within session (trial 1 vs trial 2). Estimated ICC’s for the
absolute difference and percent change of CPM stratified
by sex are reported in Table 4. In the clinical cohort only
females had ICC values approaching the commonly used
point estimate in the literature of 0.70 [42]. It should be
noted that for males the within session stability at base-
line did not exceed the recommended ICC’s threshold
score of 0.50 (for the absolute difference) [42].
In addition, analysis revealed that the shoulder pain
intensity decreased significantly [F(1, 101) = 65.83; p <
0.001] from the pre surgical time point (mean = 3.26;
SD = 2.31) to 3 months post-surgery (mean = 1.52; SD =
1.56). Repeated measures ANOVA showed a significant
difference on trial 1 and trial 2 for the absolute difference
of CPM within session 1 (before surgery) [F(1,122) =
10.55, p < 0.01]. As expected, the first CPM trial (mean =
9.05, SD = 11.79) produced significantly greater inhibition
as compared to the second CPM trial (mean = 4.69, SD =
8.29) (Figure 1). After including pain intensity as a covari-
ate no differences were found from previous results, indi-
cating that the difference between both trials of CPM
within the same session was not affected by amount of
shoulder pain.
Healthy cohort
Table 3 shows stability results from the healthy cohort
for within session (trial 1 vs trial 2), and between session
(day 1, day 3, day 5). Estimated ICC’s for the absolute
difference and percent change of CPM stratified by sex
are reported in Table 4. Males from the healthy cohort
had ICC’s values considered as high scores (for the
absolute difference) [42], whereas females had moderate
ICC’s [42].
Consistent with our previous studies [15,16], induced
shoulder pain intensity changed between day 1, day 3,
Table 1 Demographic characteristics, CPM ratings, absolute change and percent change of CPM for clinical and healthy
cohorts




Absolute change of CPM Percent change of CPM
Age 43.83 (17.80)
Sex (Female) 47 (35.1%)
(Male) 87 (64.9%)
BPI sess 1 (pre surgery) 3.28 (2.31)
BPI sess 2 (3 months) 1.56 (1.55)
Pre CPM trial 1 (pre surgery) 28.75 (23.39) 64.30 (27.39) 8.11 (11.78) 23.9%
Post CPM trial 1 (pre surgery) 20.38 (20.99)
Pre CPM trial 2 (pre surgery) 23.69 (19.99) 62.81 (27.71) 4.66 (8.23) 22.9%
Post CPM trial 2 (pre surgery) 18.96 (19.69)
Pre CPM trial 1 (3 months) 23.86 (17.35) 62.69 (27.56) 6.51 (9.33) 36.8%
Post CPM trial 1 (3 months) 17.45 (17.81)
Pre CPM trial 2 (3 months) 19.51 (16.60) 62.13 (27.73) 4.18 (10.02) 9.6%
Post CPM trial 2 (3 months) 15.33 (16.00)
Healthy cohort
Age 23.02 (6.04)
Sex (Female) 116 (61.1%)
(Male) 74 (38.9%)
BPI day 1 0.45 (0.77)
BPI day 2 2.05 (1.04)
BPI day 3 2.44 (1.71)
BPI day 5 1.23 (1.21)
Pre CPM trial 1(day 1) 20.81 (20.45) 50.19 (27.77) 9.06 (11.51) 48.4%
Post CPM trial 1 (day 1) 11.75 (14.91)
Pre CPM trial 2 (day 1) 18.09 (18.87) 50.88 (27.29) 7.08 (10.35) 46.4%
Post CPM trial 2 (day 1) 11.01 (15.14)
Pre CPM trial 1 (day 3) 20.30 (19.43) 53.97 (27.66) 9.08 (12.74) 46.6%
Post CPM trial 1 (day 3) 11.21 (14.54)
Pre CPM trial 2 (day 3) 17.66 (18.46) 52.70 (27.11) 6.99 (11.09) 41.0%
Post CPM trial 2 (day 3) 10.67 (13.52)
Pre CPM trial 1 (day 5) 19.97 (20.61) 54.37 (28.05) 8.60 (13.38) 41.7%
Post CPM trial 1 (day 5) 11.37 (14.24)
Pre CPM trial 2 (day 5) 16.95 (18.04) 51.96 (27.98) 6.27 (9.99) 39.6%
Post CPM trial 2 (day 5) 10.69 (14.39)
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nificantly from day 1 (mean = 0.45; SD = 0.77) to day 3
(mean = 2.45; SD = 1.72), and decreasing significantly
from day 3 to day 5 (mean = 1.23; SD = 1.21). Repeated
measures ANOVA showed a significant difference be-
tween trial 1 and trial 2 for the absolute difference of
CPM within day 1 [F(1,189) = 6.16, p = 0.01]. As expected,
the first CPM trial (mean = 9.06, SD = 11.51) produced
significantly greater inhibition as compared to the second
CPM trial (mean = 7.10, SD = 10.34) (Figure 2). Thesesignificant differences were maintained within day 3 and
day 5 (Figure 3). There was no significant interaction term
between CPM trial and pain intensity level (only day 3
and day 5) (p > 0.05), indicating that the difference be-
tween both trials of CPM within the same session was not
affected by pain intensity.
The between session stability (day 1, day 3, and day 5)
of CPM trial 1 [F(2,364) = 0.18, p = 0.84], did not change
significantly over time (Figure 3). In exploring whether
shoulder pain intensity influenced CPM between session
Table 2 Absolute change and percent change of CPM stratified by sex for clinical and healthy cohorts
Females Males
Clinical cohort Absolute change Percent change Absolute change Percent change
CPM trial 1 (pre surgery) 8.56 (11.39) 34.1% 8.86 (12.04) 18.9%
CPM trial 2 (pre surgery) 3.94 (7.80) 21.1% 5.06 (8.47) 23.8%
CPM trial 1 (3 months) 4.97 (9.22) 40.3% 7.04 (9.37) 35.6%
CPM trial 2 (3 months) 2.72 (7.77) 1.2% 4.69 (10.70) 12.3%
Healthy cohort
CPM trial 1 (day 1) 9.11 (11.56) 44.7% 8.96 (11.50) 54.0%
CPM trial 2 (day 1) 7.42 (11.98) 41.5% 6.55 (7.10) 54.0%
CPM trial 1 (day 3) 10.05 (13.87) 50.9% 7.62 (10.67) 39.6%
CPM trial 2 (day 3) 8.11 (13.13) 41.9% 5.27 (6.61) 39.7%
CPM trial 1 (day 5) 9.87 (14.81) 37.8% 6.66 (10.67) 47.8%
CPM trial 1 (day 5) 6.57 (10.17) 38.6% 5.81 (9.77) 41.2%
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between time (day1, day 3, day 5) and pain intensity [F
(2,362) = 1.89, p = 0.15], indicating that the between ses-
sion stability of CPM was not affected by subject’s pain
intensity. These results did not differ when exploring
CPM trial 2.
Discussion
The present study investigated whether gender and pain
intensity influence CPM stability in two different muscu-
loskeletal pain models. Our findings suggest that the sta-
bility of CPM did not appear to be related to shoulder
pain intensity in surgical or exercise induced pain co-
horts, however the stability of CPM within and between
days differed by sex. Reliability is an essential property of
any measurement that needs to be established before the
measurement can be used widely in clinical settings.
However, psychometric studies of CPM have not been
widely reported [11,43]. The data reported in this paper
are novel because to our knowledge, this is the first
study to investigate stability of CPM using the sameTable 3 Stability estimates for CPM within and between sessi
Clinical cohort ICC’s
diffe
Within session CPM trial 1-CPM trial 2 (baseline) 0.54
CPM trial 1-CPM trial 2 (3 months) 0.62
Healthy cohort
Within session CPM trial 1-CPM trial 2 (day 1) 0.66
CPM trial 1-CPM trial 2 (day 3) 0.72
CPM trial 1-CPM trial 2 (day 5) 0.70
Between session CPM trial 1 (day1)-CPM trial 1 (day3)-CPM
trial 1 (day5)
0.71(
CPM trial 2 (day1)-CPM trial 2 (day3)-CPM
trial 2 (day5)
0.68
*SEM and MDC were calculated using ICC’s for the absolute difference of CPM.protocol in subjects with 2 different forms of musculo-
skeletal pain.
We were interested in determining if the inhibition
produced by the conditioning stimulus was reliable
within the same session (trial 1 and trial 2) in a cohort
of patients before and after shoulder surgery (clinical
pain model), and in a healthy cohort before and after
pain induction (acute pain model). This is an important
issue because a measure with poor reliability is unlikely
to be valid [44]. Using the most common paradigm to
evoke endogenous pain inhibition [4,5,45], CPM proved
to suppress SHPR as a test stimulus, such that there was
a significant inhibition in trial 1 and in trial 2 (within
session) in both cohorts. As expected there was less in-
hibition in trial 2 compared with trial 1 in both cohorts
and across both sessions. The starting points in trial 2
(Pre CPM) were lower than trial 1 (Table 1), producing
potentially less room for an inhibitory effect (floor
effect). This could be explained by lingering inhibition
from the first trial, suggesting an inadequate resting
period between trials, and corroborating that the CPMons for the overall sample
for the absolute
rence (95% CI)
ICC’s for the percent
change (95% CI)
SEM* MDC*
(0.34-0.68) 0.42 (0.16-0.59) 6.79 18.82
(0.43-0.74) 0.07 (-0.51-0.36) 5.96 16.52
(0.55-0.75) 0.60(0.46-0.70) 6.37 17.66
(0.62-0.79) 0.55 (0.39-0.67) 6.30 17.46
(0.60-0.78) 0.64 (0.51-0.73) 6.40 17.74
0.62-0.77) 0.61 (0.49-0.70) 6.75 18.71
(0.60-0.76) 0.59 (0.46-0.69) 5.93 16.44
Table 4 Stability estimates for CPM within and between sessions stratified by sex for clinical and healthy cohorts
Females Males















Within session CPM trial 1-CPM trial
2 (baseline)
0.63 (0.33-0.80) 0.57 (0.19-0.78) 5.83 16.16 0.49 (0.21-0.67) 0.39 (0.05-0.61) 7.33 20.32
CPM trial 1-CPM trial
2 (3 months)
0.75 (0.43-0.89) 0.73 (0.36-0.89) 4.25 11.78 0.58 (0.32-0.73) 0.41 (-0.03-0.66) 6.50 18.02
Healthy cohort
Within session CPM trial 1-CPM trial
2 (day 1)
0.60 (0.42-0.72) 0.55 (0.34-0.69) 7.45 20.65 0.79 (0.67-0.87) 0.66 (0.45-0.79) 4.26 11.81
CPM trial 1-CPM trial
2 (day 3)
0.71 (0.57-0.80) 0.61 (0.42-0.74) 7.28 20.18 0.74 (0.58-0.84) 0.52 (0.22-0.71) 4.40 12.20
CPM trial 1-CPM trial
2 (day 5)
0.64 (0.47-0.75) 0.74 (0.61-0.82) 7.49 20.76 0.83 (0.73-0.89) 0.48 (0.13-0.68) 4.21 11.66
Between session CPM trial 1 (day1)-CPM trial
1 (day3)-CPM trial 1 (day5)
0.65 (0.51-0.75) 0.62 (0.47-0.73) 7.93 21.98 0.82 (0.73-0.88) 0.60 (0.40-0.75) 4.64 12.86
CPM trial 2 (day1)-CPM trial
2 (day3)-CPM trial 2 (day5)
0.63 (0.49-0.74) 0.61 (0.46-0.73) 7.15 19.82 0.82 (0.74-0.88) 0.58 (0.35-0.74) 3.32 9.20
*SEM and MDC were calculated using ICC’s for the absolute difference of CPM.
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authors have previously suggested [5,7,10]. Therefore,
future studies should consider a longer rest period if the
goal is to have repeated assessment of CPM within the
same session.
Stability of CPM was also assessed between sessions.
This enabled us to determine if pre and post-surgery
changes on pain intensity (for the clinical cohort), and
changes on pain intensity during one week (in the
healthy cohort), impacted the stability of the CPM para-
digm in a controlled situation. While the shoulder pain
intensity changed over time (surgical procedure signifi-
cantly decreased the amount of pain 3 months after the
surgery, and EIMP procedure in the healthy cohort in-
duced a significant amount of pain over 5 days), the
amount of inhibition remain relatively constant over
time, showing that stability of CPM seems not to be af-
fected much by a short period of time and not to be
affected by acute or sub-acute changes on pain intensity.Figure 1 Significant difference between the absolute difference
of within session (trial 1 vs trial 2) before the surgery (session
1) and 3 months after the surgery for the clinical cohort.The moderate stability of CPM in two musculoskeletal
pain models under different conditions of pain intensity,
corroborate the assumption that CPM represents a mod-
erately stable response that is largely independent of
changes in pain intensity. Even though the purpose of
our study was not directly to compare both cohorts
(clinical vs healthy), it is interesting to mention that the
conditioning stimulus (cold water bath) produced a sig-
nificant and comparable pain inhibition in both cohorts.
These results could suggest that the ongoing pain in the
clinical cohort and the induced pain in the healthy co-
hort did not affect the mechanisms of CPM, reinforcing
the idea of the moderately stable nature of this measure,
and confirming using cold water bath as a conditioning
stimulus as was previously recommended [4,5]. In terms
of CPM calculations, our results further confirm theFigure 2 Significant difference between the absolute difference
of within session (trial 1 vs trial 2) on day 1, day 3, and day 5
for the healthy cohort.
Figure 3 Significant difference between the absolute difference
of between sessions (day 1, day 3, and day 5) for the
healthy cohort.
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when reporting CMP [4]. Not surprisingly, the ICC’s cal-
culated with the percent change had lower reliability
values. This could be explained by the different informa-
tion that each calculation provides, where the absolute
difference represents the absolute magnitude of change,
and the percent change accounts for the subject’s base-
line level of sensitization.
Regarding the influence of sex on CPM stability within
and between sessions, the present study revealed that
the stability of CPM within and between days differed by
sex (Tables 2 and 4). A number of studies using widely
different methodologies have investigated sex differences
in experimental pain sensitivity [12] using CPM, or other
paradigms. Some researchers suggest less efficient CPM
in women than men [14,26,46] while other studies did
not detect sex differences in CPM [47,48]. Several fac-
tors have been proposed to explain sex differences; how-
ever the stability of this experimental pain measure
across sexes had not been explored before. In this study,
ICC’s stratified by sex showed that males from the
clinical cohort showed lower scores than females (within
session), and the females from the healthy cohort showed
lower scores than males (within and between session for
the absolute difference). Furthermore, the standard error
of measurement (SEM) is directly related to the reliability
of a test; that is, the larger the SEM, the lower the reliabil-
ity of the test and the less precision in the measures taken
and scores obtained. Consequently, our results showed a
large difference on SEM between males and females,
where males from the healthy cohort and females from
the clinical cohort had lower levels of standard error of
measurement indicating higher levels of score consistency.
The results of the present study in two musculoskel-
etal pain models suggest that the most stable situation
to use a CPM paradigm is in females from the clinical
cohort (where changes need to exceed a MDC of 16 to
exceed measurement error) and males from the healthycohort (where changes need to exceed a MDC of 12 to
exceed measurement error). This has a direct clinical
implication because whether sex affects reliability of
CPM, or whether the amount of measurement variation
differs across sex may lead to biased clinical results and
biased clinical implications. This differences on CPM
stability between sex could potentially explain the contra-
dictory results in the literature using CPM as a measure of
central pain processing [3,9,12,49,50], because a lack of
reliability does potentially limit the overall validity of a
measure. A speculative explanation for our results could
be found on differences on psychological factors associ-
ated with this experimental pain measure [1,51,52], differ-
ences in expectation between sex [53], effect of distraction
between sex [26], menstrual cycle effect [54], however fu-
ture clinical studies need to explore whether these factors
directly affect CPM stability.
Previous studies investigating endogenous pain modula-
tion in chronic pain populations have shown a potential
deficiency of pain inhibitory system [3,6,7,10,12,26,50,55].
It has also been shown that CPM could be a predictor for
post operative pain and potentially sensitive to changes in
the central nervous system [3,50]. However, since CPM is
a proxy measure of central pain inhibitory process, t, it is
particularly important to estimate the error associated
with this commonly used measure in order to be useful in
research and clinical decision making. After performing a
reliability analysis in these two cohorts and establishing
that CPM is a measure moderately stable independent of
changes in pain intensity, we are in a better stage to use
this measure in clinical settings (from a reliability stand
point). If we think that CPM is a proxy measure of central
pain inhibitory system, with a moderate reliability we may
speculate that higher stability may be expected when
assessing a population with chronic pain (which may have
less variability in central sensitization), however future
studies need to be performed to test this hypothesis.
Some important limitations of this study will need to
be addressed by future research. First, this investigation
was part of a larger study; therefore the procedures were
not designed solely for the purpose of establishing CPM
stability. Second, this investigation would have been en-
hanced by adding a control condition where CPM test-
ing was repeated on a second pain-free day. In addition,
even though the purpose of the study was not to assess
the reliability of CPM in the clinical cohort before and
after the surgery, our within session analysis could be af-
fected by the effect of drugs. Future studies should con-
sider the potential effect of drugs before and after the
surgery. Lastly, some authors have reported significant sex
differences in pain report associated with experimenter
sex. The present study examined the effect of sex on
CPM, however we did not control for experimenter sex ef-
fect, menstrual cycle phases or contraceptive use. Future
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tigate the influence of other relevant demographic charac-
teristic (such as race or ethnicity) on CPM stability.
Despite these limitations, the current study represents
a novel contribution to the literature by identifying fac-
tors that influence CPM stability in two different muscu-
loskeletal shoulder pain models. Evidence suggests that
altered central processing of noxious stimuli might be
relevant in the pathogenesis of pain disorders [55-58].
However, establishing the stability of a measurement is
essential before consider CPM a clinically useful meas-
ure. Our results suggest that 1) CPM stability is not re-
lated to changes in pain intensity, and 2) there are sex
differences for CPM stability within and between days.
Applying these results to clinical psychophysics, our
study suggest that the fluctuation of shoulder pain inten-
sity did not significantly affect CPM stability, this could
reiterate the moderately stable nature of this construct
and the relative consistency of this commonly used ex-
perimental pain measure.Conclusions
This study assessed whether shoulder pain intensity and
gender influence CPM stability in two musculoskeletal
pain models. Our results provide evidence that the fluc-
tuation of pain intensity did not significantly influence
CPM stability. In addition, there are sex differences for
CPM stability within and between days, where the more
stable situations for CPM were females from the clinical
cohort and males from the healthy cohort.
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